Robert Nelsen - Director, 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Nelsen since 12/3/2023

Holdings reported by Robert Nelsen for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18.2M $41.5M $2.28 Jun 14, 2024 ARCH Venture Fund IX,L.P.
Common Stock 18.2M $41.5M $2.28 Jun 14, 2024 ARCH Venture Fund IX Overage, L.P.
Option (right to buy) 130K Jun 14, 2024 Direct Common Stock

Transactions reported by Robert Nelsen for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.